Another Paragon offshoot inks reverse merger as Jade takes Aerovate’s place

Paragon Ther­a­peu­tics, a com­pa­ny that spins out an­ti­body biotechs, has forged a sec­ond re­verse merg­er for its port­fo­lio this week.

Its au­toim­mune spin­off Jade Bio­sciences …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.